Literature DB >> 14888694

The systemic toxic responses of patients to treatment with streptokinase streptodornase.

W N HUBBARD.   

Abstract

Entities:  

Keywords:  STREPTODORNASE AND STREPTOKINASE/therapeutic use

Mesh:

Substances:

Year:  1951        PMID: 14888694      PMCID: PMC436359          DOI: 10.1172/JCI102536

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  2 in total

1.  THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.

Authors:  W S Tillett; S Sherry
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

2.  Streptococcal enzymatic debridement.

Authors:  W S TILLETT; S SHERRY
Journal:  Ann Surg       Date:  1950-01       Impact factor: 12.969

  2 in total
  3 in total

1.  The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients.

Authors:  W S TILLETT; A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

2.  Flow resistance of individual neutrophils in coronary artery disease: decreased pore transit times in acute myocardial infarction.

Authors:  R M Bauersachs; G Moessmer; C Koch; F J Neumann; H J Meiselman; C Pfafferott
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

3.  A history of streptokinase use in acute myocardial infarction.

Authors:  Nikhil Sikri; Amit Bardia
Journal:  Tex Heart Inst J       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.